In fact, many scRNAseq data sets show overlapping patterns of myeloid IL4i1 and IDO1 expression in the TME raising the possibility that (i) this is a universal response in the chronic inflammation of cancer and (ii) that multiple factors may control the expression of both enzymes. This evidence concerns the gene IL4I1 and cancer.